Related references
Note: Only part of the references are listed.Fatty liver indices in the multiethnic United States National Health and Nutrition Examination Survey
C. E. Ruhl et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2015)
Systematic review with meta-analysis: non-invasive assessment of non-alcoholic fatty liver disease - the role of transient elastography and plasma cytokeratin-18 fragments
R. Kwok et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2014)
Performance and limitations of steatosis biomarkers in patients with nonalcoholic fatty liver disease
L. Fedchuk et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2014)
Circulating CD36 and oxLDL levels are associated with cardiovascular risk factors in young subjects
Luz E. Ramos-Arellano et al.
BMC CARDIOVASCULAR DISORDERS (2014)
Effect of aerobic exercise and low carbohydrate diet on pre-diabetic non-alcoholic fatty liver disease in postmenopausal women and middle aged men - the role of gut microbiota composition: study protocol for the AELC randomized controlled trial
Wu Yi Liu et al.
BMC PUBLIC HEALTH (2014)
Abdominal subcutaneous adipose tissue insulin resistance and lipolysis in patients with non-alcoholic steatohepatitis
M. J. Armstrong et al.
DIABETES OBESITY & METABOLISM (2014)
Genetic susceptibility to type 2 diabetes and obesity: from genome-wide association studies to rare variants and beyond
Niels Grarup et al.
DIABETOLOGIA (2014)
Increased De Novo Lipogenesis Is a Distinct Characteristic of Individuals With Nonalcoholic Fatty Liver Disease
Jennifer E. Lambert et al.
GASTROENTEROLOGY (2014)
Nonalcoholic Steatohepatitis Is the Most Rapidly Growing Indication for Liver Transplantation in Patients With Hepatocellular Carcinoma in the U. S.
Robert J. Wong et al.
HEPATOLOGY (2014)
Dysbiosis Contributes to Fibrogenesis in the Course of Chronic Liver Injury in Mice
Samuele De Minicis et al.
HEPATOLOGY (2014)
High Prevalence of Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels
Paola Portillo Sanchez et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
A single non-invasive model to diagnose non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH)
Munkhzul Otgonsuren et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2014)
Controlled attenuation parameter (CAP) for the diagnosis of steatosis: A prospective study of 5323 examinations
Victor de Ledinghen et al.
JOURNAL OF HEPATOLOGY (2014)
Lipid Peroxidation: Production, Metabolism, and Signaling Mechanisms of Malondialdehyde and 4-Hydroxy-2-Nonenal
Antonio Ayala et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2014)
Comparison of Liver Fat Indices for the Diagnosis of Hepatic Steatosis and Insulin Resistance
Sabine Kahl et al.
PLOS ONE (2014)
Liver transplantation and non-alcoholic fatty liver disease
Petros Zezos et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome
Hannele Yki-Jarvinen
LANCET DIABETES & ENDOCRINOLOGY (2014)
Adipose tissue insulin resistance in adolescents with and without type 2 diabetes
M. M. Kelsey et al.
PEDIATRIC OBESITY (2014)
Safety and efficacy of liraglutide in patients with type 2 diabetes and elevated liver enzymes: individual patient data meta-analysis of the LEAD program
M. J. Armstrong et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2013)
Cohort Study of Non-alcoholic Fatty Liver Disease, NAFLD fibrosis score, and the Risk of Incident Diabetes in a Korean population
Yoosoo Chang et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
Sugar, Uric Acid, and the Etiology of Diabetes and Obesity
Richard J. Johnson et al.
DIABETES (2013)
Exenatide once weekly improved glycaemic control, cardiometabolic risk factors and a composite index of an HbA1c < 7%, without weight gain or hypoglycaemia, over 52 weeks
R. M. Bergenstal et al.
DIABETES OBESITY & METABOLISM (2013)
Genetic association of ADIPOQ gene variants with type 2 diabetes, obesity and serum adiponectin levels in south Indian population
Kandaswamy Ramya et al.
GENE (2013)
Genomic aspects of NAFLD pathogenesis
Adviti Naik et al.
GENOMICS (2013)
Nonalcoholic Fatty Liver Disease: A Novel Cardiometabolic Risk Factor for Type 2 Diabetes and Its Complications
Giovanni Targher et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Association of glucokinase regulatory protein polymorphism with type 2 diabetes and fasting plasma glucose: a meta-analysis
Hong Li et al.
MOLECULAR BIOLOGY REPORTS (2013)
Non-alcoholic fatty liver disease independently predicts prediabetes during a 7-year prospective follow-up
Shira Zelber-Sagi et al.
LIVER INTERNATIONAL (2013)
Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis
Quentin M. Anstee et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2013)
The genetics of NAFLD
Quentin M. Anstee et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2013)
Non-alcoholic steatohepatitis: a microbiota-driven disease
Alexander R. Moschen et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2013)
Non-Alcoholic Fatty Liver Disease (NAFLD) and Its Connection with Insulin Resistance, Dyslipidemia, Atherosclerosis and Coronary Heart Disease
Melania Gaggini et al.
NUTRIENTS (2013)
Noninvasive biomarkers for the diagnosis of steatohepatitis and advanced fibrosis in NAFLD
Steven G. Pearce et al.
BIOMARKER RESEARCH (2013)
Liver Stiffness Measurement Using XL Probe in Patients With Nonalcoholic Fatty Liver Disease
Vincent Wai-Sun Wong et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2012)
Can Nash Be Diagnosed, Graded, and Staged Noninvasively?
Garfield A. Grandison et al.
CLINICS IN LIVER DISEASE (2012)
Circulating Levels of Phthalate Metabolites Are Associated With Prevalent Diabetes in the Elderly
P. Monica Lind et al.
DIABETES CARE (2012)
Sedentary time in adults and the association with diabetes, cardiovascular disease and death: systematic review and meta-analysis
E. G. Wilmot et al.
DIABETOLOGIA (2012)
Serum concentrations of phthalate metabolites are related to abdominal fat distribution two years later in elderly women
P. Monica Lind et al.
ENVIRONMENTAL HEALTH (2012)
Role of Obesity and Lipotoxicity in the Development of Nonalcoholic Steatohepatitis: Pathophysiology and Clinical Implications
Kenneth Cusi
GASTROENTEROLOGY (2012)
Association between diabetes, family history of diabetes, and risk of nonalcoholic steatohepatitis and fibrosis
Rohit Loomba et al.
HEPATOLOGY (2012)
Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease
Romina Lomonaco et al.
HEPATOLOGY (2012)
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
Naga Chalasani et al.
HEPATOLOGY (2012)
Dysfunctional Adiposity and the Risk of Prediabetes and Type 2 Diabetes in Obese Adults
Ian J. Neeland et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Hepatocellular carcinoma in non-alcoholic fatty liver disease: An emerging menace
Gyoergy Baffy et al.
JOURNAL OF HEPATOLOGY (2012)
Nonalcoholic Fatty Liver Disease in Lean Individuals in the United States
Zobair M. Younossi et al.
MEDICINE (2012)
Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults
G. Vernon et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Non-Invasive markers for hepatic fibrosis
Ancha Baranova et al.
BMC GASTROENTEROLOGY (2011)
Oxidized LDL and the Risk of Coronary Heart Disease: Results from the MONICA/KORA Augsburg Study
Wolfgang Koenig et al.
CLINICAL CHEMISTRY (2011)
Why Does NAFLD Predict Type 2 Diabetes?
Guido Lattuada et al.
CURRENT DIABETES REPORTS (2011)
The Metabolically Benign and Malignant Fatty Liver
Norbert Stefan et al.
DIABETES (2011)
The Paradox of Progress: Environmental Disruption of Metabolism and the Diabetes Epidemic
Brian A. Neel et al.
DIABETES (2011)
Role of beta-cell dysfunction, ectopic fat accumulation and insulin resistance in the pathogenesis of type 2 diabetes mellitus
Amalia Gastaldelli
DIABETES RESEARCH AND CLINICAL PRACTICE (2011)
IDF Diabetes Atlas: Global estimates of the prevalence of diabetes for 2011 and 2030
David R. Whiting et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2011)
Association Study of IRS1 Gene Polymorphisms with Type 2 Diabetes in South Indians
Dhanasekaran Bodhini et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2011)
Dissociation between fatty liver and insulin resistance: the role of adipose triacylglycerol lipase
N. Stefan et al.
DIABETOLOGIA (2011)
Clinical feasibility of liver elastography by acoustic radiation force impulse imaging (ARFI)
Kinan Rifai et al.
DIGESTIVE AND LIVER DISEASE (2011)
The diagnostic accuracy of US, CT, MRI and H-1-MRS for the evaluation of hepatic steatosis compared with liver biopsy: a meta-analysis
Anneloes E. Bohte et al.
EUROPEAN RADIOLOGY (2011)
Etiology-related determinants of liver stiffness values in chronic viral hepatitis B or C
Mirella Fraquelli et al.
JOURNAL OF HEPATOLOGY (2011)
Nutrition and physical activity in NAFLD: An overview of the epidemiological evidence
Shira Zelber-Sagi et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2011)
Obesity, insulin resistance and free fatty acids
Guenther Boden
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY (2011)
Type 2 diabetes as an inflammatory disease
Marc Y. Donath et al.
NATURE REVIEWS IMMUNOLOGY (2011)
Nonalcoholic Fatty Liver Disease: Focus on Lipoprotein and Lipid Deregulation
Klementina Fon Tacer et al.
JOURNAL OF LIPIDS (2011)
The Association Between the Peroxisome Proliferator-Activated Receptor-γ2 (PPARG2) Pro12Ala Gene Variant and Type 2 Diabetes Mellitus: A HuGE Review and Meta-Analysis
Hebe N. Gouda et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2010)
A simple index of lipid overaccumulation is a good marker of liver steatosis
Giorgio Bedogni et al.
BMC GASTROENTEROLOGY (2010)
Genetic control of de novo lipogenesis: role in diet-induced obesity
Maggie S. Strable et al.
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY (2010)
Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009
R. A. DeFronzo
DIABETOLOGIA (2010)
Hepatic steatosis index: A simple screening tool reflecting nonalcoholic fatty liver disease
Jeong-Hoon Lee et al.
DIGESTIVE AND LIVER DISEASE (2010)
Persistent Organic Pollutant Exposure Leads to Insulin Resistance Syndrome
Jerome Ruzzin et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2010)
Genetic variants regulating insulin receptor signalling are associated with the severity of liver damage in patients with non-alcoholic fatty liver disease
P. Dongiovanni et al.
GUT (2010)
Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease
Stuart McPherson et al.
GUT (2010)
Long-Term Efficacy of Rosiglitazone in Nonalcoholic Steatohepatitis: Results of the Fatty Liver Improvement by Rosiglitazone Therapy (FLIRT 2) Extension Trial
Vlad Ratziu et al.
HEPATOLOGY (2010)
Liver Enzymes, Nonalcoholic Fatty Liver Disease, and Incident Cardiovascular Disease: A Narrative Review and Clinical Perspective of Prospective Data
Nazim Ghouri et al.
HEPATOLOGY (2010)
Evolution of Inflammation in Nonalcoholic Fatty Liver Disease: The Multiple Parallel Hits Hypothesis
Herbert Tilg et al.
HEPATOLOGY (2010)
Impact of environmental endocrine disrupting chemicals on the development of obesity
Retha R. Newbold
HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM (2010)
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis.
Arun J. Sanyal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Comparison of Noninvasive Markers of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
Amy G. Shah et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2009)
Hepatic Stearoyl-CoA Desaturase (SCD)-1 Activity and Diacylglycerol but Not Ceramide Concentrations Are Increased in the Nonalcoholic Human Fatty Liver
Anna Kotronen et al.
DIABETES (2009)
Role of glucotoxicity and lipotoxicity in the pathophysiology of Type 2 diabetes mellitus and emerging treatment strategies
S. Del Prato
DIABETIC MEDICINE (2009)
Prediction of Non-Alcoholic Fatty Liver Disease and Liver Fat Using Metabolic and Genetic Factors
Anna Kotronen et al.
GASTROENTEROLOGY (2009)
Transcription Factor 7-Like 2 Polymorphism Modulates Glucose and Lipid Homeostasis, Adipokine Profile, and Hepatocyte Apoptosis in NASH
Giovanni Musso et al.
HEPATOLOGY (2009)
Increased Intestinal Permeability and Tight Junction Alterations in Nonalcoholic Fatty Liver Disease
Luca Miele et al.
HEPATOLOGY (2009)
Fatty Liver Is Associated with Insulin Resistance, Risk of Coronary Heart Disease, and Early Atherosclerosis in a Large European Population
Amalia Gastaldelli et al.
HEPATOLOGY (2009)
Comparison of blood tests for liver fibrosis specific or not to NAFLD
Paul Cales et al.
JOURNAL OF HEPATOLOGY (2009)
PPAR-mediated activity of phthalates: A link to the obesity epidemic?
Beatrice Desvergne et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2009)
Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD)
Giovanni Musso et al.
PROGRESS IN LIPID RESEARCH (2009)
The common P446L polymorphism in GCAR inversely modulates fasting glucose and triglyceride levels and reduces type 2 diabetes risk in the DESIR prospective general French population
Martine Vaxillaire et al.
DIABETES (2008)
Association of urinary phthalate metabolite concentrations with body mass index and waist circumference: a cross-sectional study of NHANES data, 1999-2002
Elizabeth E. Hatch et al.
ENVIRONMENTAL HEALTH (2008)
Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis
Guruprasad P. Aithal et al.
GASTROENTEROLOGY (2008)
Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease
S. A. Harrison et al.
GUT (2008)
Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: A role for insulin resistance and diabetes
Anna Ludovica Fracanzani et al.
HEPATOLOGY (2008)
Effects of endocrine disruptors on obesity
Retha R. Newbold et al.
INTERNATIONAL JOURNAL OF ANDROLOGY (2008)
Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice
Catherine Postic et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis
Fabio Marra et al.
TRENDS IN MOLECULAR MEDICINE (2008)
Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European liver fibrosis panel and exploring simple markers
Indra Neil Guha et al.
HEPATOLOGY (2008)
Liver eat is increased in type 2 diabetic patients and underestimated by serum alanine aminotransferase compared with equally obese nondiabetic sub jets
Anna Kotronen et al.
DIABETES CARE (2008)
Benefits of lifestyle modification in NAFLD
Stephen A. Harrison et al.
GUT (2007)
Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes
Valeriya Lyssenko et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects
Amalia Gastaldelli et al.
GASTROENTEROLOGY (2007)
Metabolic stress in insulin's target cells leads to ROS accumulation - A hypothetical common pathway causing insulin resistance
Jan W. Eriksson
FEBS LETTERS (2007)
The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD
Paul Angulo et al.
HEPATOLOGY (2007)
Association between serum concentrations of persistent organic pollutants and insulin resistance among nondiabetic adults
Duk-Hee Lee et al.
DIABETES CARE (2007)
Metabolic effects of two years of exenatide treatment on diabetes, obesity, and hepatic biomarkers in patients with type 2 diabetes: An interim analysis of data from the open-label, uncontrolled extension of three double-blind, placebo-controlled trials
John B. Buse et al.
CLINICAL THERAPEUTICS (2007)
A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis
Renata Belfort et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population
Giorgio Bedogni et al.
BMC GASTROENTEROLOGY (2006)
Long-term follow-up of patients with NAFLD and elevated liver enzymes
Mattias Ekstedt et al.
HEPATOLOGY (2006)
The role of bright liver echo pattern on ultrasound B-mode examination in the diagnosis of liver steatosis
B. Palmentieri et al.
DIGESTIVE AND LIVER DISEASE (2006)
A strong dose-response relation between serum concentrations of persistent organic pollutants and diabetes - Results from the National Health and Examination Survey 1999-2002
Duk-Hee Lee et al.
DIABETES CARE (2006)
Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis C
AJ Sanyal et al.
HEPATOLOGY (2006)
Macrovesicular hepatic steatosis in living liver donors: Use of CT for quantitative and qualitative assessment
SH Park et al.
RADIOLOGY (2006)
Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes
SFA Grant et al.
NATURE GENETICS (2006)
The effect of rosiglitazone on the liver: Decreased gluconeogenesis in patients with type 2 diabetes
A Gastaldelli et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Computed tomography in nonalcoholic fatty liver disease -: A useful tool for hepatosteatosis assessment?
DG Duman et al.
DIGESTIVE DISEASES AND SCIENCES (2006)
NF-κB activation, rather than TNF, mediates hepatic inflammation in a murine dietary model of steatohepatitis
A Dela Peña et al.
GASTROENTEROLOGY (2005)
Dose-response effect of elevated plasma free fatty acid on insulin signaling
R Belfort et al.
DIABETES (2005)
Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms
E Bugianesi et al.
DIABETOLOGIA (2005)
Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population
LS Szczepaniak et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2005)
Separate contribution of diabetes, total fat mass, and fat topography to glucose production, gluconeogenesis, and glycogenolysis
A Gastaldelli et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity
JD Browning et al.
HEPATOLOGY (2004)
Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IκB-α
SI Itani et al.
DIABETES (2002)
Liver fibrosis in overweight patients
V Ratziu et al.
GASTROENTEROLOGY (2000)
Share Paper
